• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Keywords » fentanyl

Items Tagged with 'fentanyl'

ARTICLES

shutterstock_2432683359.jpg

Hidden Dangers: The Fentanyl Crisis and Teen Overdose Prevention

March 31, 2025
Joshua Feder, MD and Mara Goverman
The Fentanyl overdose crisis is now one of the leading causes of death among adolescents, and it is happening in every corner of the country. Stay with us as we talk about the state of the crisis and the steps we can take to save lives.
Read More
Expert Q&A

Addressing the Overdose Crisis: What You Can Do

January 1, 2025
Aaron Quiggle, MD, MS
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

CCPR_QA1_Aaron Quiggle_photo.jpgAaron Quiggle, MD, MS

Adult, child, and adolescent addiction psychiatrist; Medical Director, Addiction Recovery Management Service (ARMS), Massachusetts General Hospital, Boston, MA.

Dr. Quiggle is a co-investigator of an investigator-sponsored trial for Ironshore Pharmaceuticals. Relevant financial relationships have been mitigated. 

There are multiple ways that we can help our patients reduce the risk of overdose. In our interview with Dr. Aaron Quiggle, we cover screening, fentanyl testing, the use of Narcan and the importance of learning to prescribe buprenorphine.


Read More

Note From the Editor-in-Chief

July 1, 2024
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Joshua D. Feder, MD. 

Dr. Feder remains alarmed: right now, it’s about heat, social media, and fentanyl  - hear his direct advice and protect your patients and yourselves from the current ravages of our times. 


Read More

Note From the Editor-in-Chief

November 1, 2023
Joshua D. Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Joshua D. Feder, MD. 

Can prescribers do cognitive behavioral therapy for obsessive compulsive disorder (OCD)? How do you treat OCD when it’s mixed with other conditions? What to tell families asking for invasive Deep Brain Stimulation for OCD? How can we minimize the problems of antipsychotics? And what about lithium – should you use it more? Join us and learn!


Read More
CATR_JulAugSept_cover_shutterstock_1572207760.jpg
Expert Q&A

The State of Opioids on the Street

May 29, 2023
Daniel Ciccarone, MD, MPH
From The Carlat Addiction Treatment Report
Issue Links: Editorial Information | PDF of Issue

CATR_QA1_headshot_DanielCiccarone.jpgDaniel Ciccarone, MD, MPH. 

Justine Miner Professor of Addiction Medicine at the University of California San Francisco.

Dr. Ciccarone is a member of the scientific advisory board for Celero Systems. Relevant financial relationships listed for the author have been mitigated.

Dr. Ciccarone sheds light on the current chaotic and perilous situation surrounding illicit opioids found on the streets.


Read More
testresults.jpeg
Expert Q&A

Interpreting Urine Drug Tests

April 1, 2023
Karen Moeller, PharmD
From The Carlat Hospital Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

QA1_UrineDrugScreens_Moeller_headshot.jpgKaren Moeller, PharmD. Clinical professor, Department of Pharmacy Practice, University of Kansas School of Pharmacy. Lawrence, KS. Board-certified psychiatric pharmacist, inpatient psychiatry unit, University of Kansas Health Systems. Kansas City, KS.

Dr. Moeller has no financial relationships with companies related to this material.

Drug screen accuracy depends on several factors, including the type of lab test, the number of hours since the patient’s use of the drug, and more.. Dr. Moeller reviews key points.


Read More

Drug Overdoses in the US: Trends and Prevention Strategies

November 5, 2021
Joshua Sharfstein, MD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Joshua Sharfstein, MDJoshua Sharfstein, MD

Professor of the Practice of Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD.

Dr. Sharfstein has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Increases in drug overdose mortality continues unabated around the country driven by widespread availability of illicit fentanyl and methamphetamines. Dr. Sharfstein provides context to these concerning trends and discusses prevention and harm reduction strategies clinicians can implement for their patients.
Read More

A New Buprenorphine Dosing Strategy for Easier Induction From Fentanyl

November 5, 2021
Oluwole Jegede, MD, PhD
From The Carlat Addiction Treatment Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Oluwole Jegede, MD. Dr. Jegede has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.
Avoiding buprenorphine induced withdrawal during induction can be particularly tricky for those using fentanyl. Researchers describe a novel induction dosing strategy that mitigates this risk.
Read More
Carlat Total Access Subscriptions: Get access to every article on the website.

Complete access to every article you search on the website.

Shop for Total Access
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • HospPsychiatry_Spiral_Binding_Sm.png

    Hospital Psychiatry Fact Book, First Edition (2025) - Spiral Bound

    This comprehensive guide is designed to be a valuable resource for professionals working in...
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2622607431.jpg
    General Psychiatry

    Should You Test MTHFR?

    MTHFR is a...
    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.